J Korean Neurosurg Soc.  2012 Jun;51(6):328-333. 10.3340/jkns.2012.51.6.328.

Increased Vascular Endothelial Growth Factor in the Ventricular Cerebrospinal Fluid as a Predictive Marker for Subsequent Ventriculoperitoneal Shunt Infection : A Comparison Study among Hydrocephalic Patients

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 2Department of Neurosurgery, Korea University Medical Center, Korea University College of Medicine, Seoul, Korea. doctorns@korea.com
  • 3Center of Innovative Cell Therapy and Research, Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • 4Department of Neurosurgery, Dongrae Wooridul Hospital, Busan, Korea.

Abstract


OBJECTIVE
The aim of this study is to determine the association between the cerebrospinal fluid (CSF) biomarkers and inflammation, and the predictive value of these CSF biomarkers for subsequent shunt associated infection.
METHODS
We obtained CSF samples from the patients with hydrocephalus during ventriculoperitoneal (VP) shunt operations. Twenty-two patients were enrolled for this study and divided into 3 groups: subarachnoid hemorrhage (SAH)-induced hydrocephalus, idiopathic normal pressure hydrocephalus (INPH) and hydrocephalus with a subsequent shunt infection. We analyzed the transforming growth factor-beta1, tumor necrosis factor-alpha, vascular endothelial growth factor (VEGF) and total tau in the CSF by performing enzyme-linked immunosorbent assay. The subsequent development of shunt infection was confirmed by the clinical presentations, the CSF parameters and CSF culture from the shunt devices.
RESULTS
The mean VEGF concentration (+/-standard deviation) in the CSF of the SAH-induced hydrocephalus, INPH and shunt infection groups was 236+/-138, 237+/-80 and 627+/-391 pg/mL, respectively. There was a significant difference among the three groups (p=0.01). Between the SAH-induced hydrocephalus and infection groups and between the INPH and infection groups, there was a significant difference of the VEGF levels (p<0.01). However, the other marker levels did not differ among them.
CONCLUSION
The present study showed that only the CSF VEGF levels are associated with the subsequent development of shunt infection. Our results suggest that increased CSF VEGF could provide a good condition for bacteria that are introduced at the time of surgery to grow in the brain, rather than reflecting a sequel of bacterial infection before VP shunt.

Keyword

Cerebrospinal fluid; Shunt infection; Biomarkers; Vascular endothelial growth factor; Hydrocephalus

MeSH Terms

Bacteria
Bacterial Infections
Biomarkers
Brain
Enzyme-Linked Immunosorbent Assay
Humans
Hydrocephalus
Hydrocephalus, Normal Pressure
Inflammation
Subarachnoid Hemorrhage
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A
Ventriculoperitoneal Shunt
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A

Reference

1. Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg. 1997; 87:247–251. PMID: 9254088.
Article
2. Cheng SY, Nagane M, Huang HS, Cavenee WK. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci U S A. 1997; 94:12081–12087. PMID: 9342366.
Article
3. Del Bigio MR. Hydrocephalus-induced changes in the composition of cerebrospinal fluid. Neurosurgery. 1989; 25:416–423. PMID: 2570370.
Article
4. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol. 1998; 140:947–959. PMID: 9472045.
Article
5. Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, Jackowski A, et al. Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage : titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab. 2001; 21:157–162. PMID: 11176281.
Article
6. Garges HP, Moody MA, Cotten CM, Smith PB, Tiffany KF, Lenfestey R, et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics. 2006; 117:1094–1100. PMID: 16585303.
Article
7. Geracioti TD Jr, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab. 1992; 74:1325–1330. PMID: 1317385.
Article
8. Gjerris A, Gjerris F, Sørensen PS, Sørensen EB, Christensen NJ, Fahrenkrug J, et al. Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level? Acta Neurochir (Wien). 1988; 91:55–59. PMID: 2899378.
Article
9. Harrigan MR, Ennis SR, Masada T, Keep RF. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery. 2002; 50:589–598. PMID: 11841728.
Article
10. Hayashi T, Abe K, Suzuki H, Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke. 1997; 28:2039–2044. PMID: 9341716.
Article
11. Heep A, Stoffel-Wagner B, Bartmann P, Benseler S, Schaller C, Groneck P, et al. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Pediatr Res. 2004; 56:768–774. PMID: 15319463.
Article
12. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest. 1999; 79:417–425. PMID: 10211994.
13. Johnson MD, Gold LI, Moses HL. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid. Lab Invest. 1992; 67:360–368. PMID: 1328762.
14. Jones KL, Krous HF, Nadeau J, Blackbourne B, Zielke HR, Gozal D. Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: evidence for antecedent hypoxia. Pediatrics. 2003; 111:358–363. PMID: 12563064.
Article
15. Koehne P, Hochhaus F, Felderhoff-Mueser U, Ring-Mrozik E, Obladen M, Bührer C. Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus. Childs Nerv Syst. 2002; 18:137–141. PMID: 11981620.
Article
16. Koehne P, Willam C, Strauss E, Schindler R, Eckardt KU, Bührer C. Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am J Physiol Heart Circ Physiol. 2000; 279:H817–H824. PMID: 10924082.
Article
17. Krupinski J, Kumar P, Kumar S, Kaluza J. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke. 1996; 27:852–857. PMID: 8623105.
Article
18. Kudo T, Mima T, Hashimoto R, Nakao K, Morihara T, Tanimukai H, et al. Tau protein is a potential biological marker for normal pressure hydrocephalus. Psychiatry Clin Neurosci. 2000; 54:199–202. PMID: 10803815.
Article
19. Lenfestey RW, Smith PB, Moody MA, Clark RH, Cotten CM, Seed PC, et al. Predictive value of cerebrospinal fluid parameters in neonates with intraventricular drainage devices. J Neurosurg. 2007; 107:209–212. PMID: 17918526.
Article
20. Li X, Miyajima M, Jiang C, Arai H. Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci Lett. 2007; 413:141–144. PMID: 17194537.
Article
21. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol. 2006; 168:639–648. PMID: 16436677.
Article
22. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A. 1998; 95:15809–15814. PMID: 9861052.
Article
23. Nag S, Takahashi JL, Kilty DW. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol. 1997; 56:912–921. PMID: 9258261.
Article
24. Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res. 2000; 119:139–153.
Article
25. Patt S, Danner S, Théallier-Jankó A, Breier G, Hottenrott G, Plate KH, et al. Upregulation of vascular endothelial growth factor in severe chronic brain hypoxia of the rat. Neurosci Lett. 1998; 252:199–202. PMID: 9739995.
Article
26. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995; 92:905–909. PMID: 7846076.
Article
27. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol. 1999; 58:654–666. PMID: 10374756.
Article
28. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975; 131:543–552. PMID: 1127260.
Article
29. Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V, Rodriguez-Wolf M, et al. Human choroid plexus growth factors : What are the implications for CSF dynamics in Alzheimer's disease? Exp Neurol. 2001; 167:40–47. PMID: 11161591.
Article
30. Tarkowski E, Tullberg M, Fredman P, Wikkelsö C. Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging. 2003; 24:707–714. PMID: 12885578.
31. Tarnaris A, Watkins LD, Kitchen ND. Biomarkers in chronic adult hydrocephalus. Cerebrospinal Fluid Res. 2006; 3:11. PMID: 17020616.
Article
32. van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, et al. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J. 2004; 23:608–613. PMID: 15247597.
Article
33. van der Flier M, Stockhammer G, Vonk GJ, Nikkels PG, van Diemen-Steenvoorde RA, van der Vlist GJ, et al. Vascular endothelial growth factor in bacterial meningitis : detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis. 2001; 183:149–153. PMID: 11106541.
Article
34. Yang J, Dombrowski SM, Deshpande A, Krajcir N, Luciano MG. VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus. J Neurol Sci. 2010; 296:39–46. PMID: 20619858.
Article
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr